Brief: Lifecore Biomedical Sees 2024 Rev In The Range Of $125 mln to $130 mln
April 1 (Reuters) - Lifecore Biomedical Inc LFCR.O :
* LIFECORE BIOMEDICAL PROVIDES BUSINESS UPDATE OUTLINING
FISCAL
2024 OUTLOOK AND YEAR-TO-DATE PROGRESS
* LIFECORE BIOMEDICAL INC: SEES 2024 REVENUE TO BE IN RANGE
OF
$125 MILLION TO $130 MILLION
* LIFECORE BIOMEDICAL INC: BELIEVES IT HAS SUFFICIENT
LIQUIDITY TO
ACHIEVE ITS STRATEGIC PLAN OVER NEXT 12 MONTHS AS OF DATE HEREOF
Source text for Eikon: ID:nGNX8P9yN
Further company coverage: LFCR.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Lifecore Biomedical
See all newsNASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 08:40 AM
Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Lifecore Biomedical Reports Financial Results
Lifecore Biomedical Inc expected to post a loss of 22 cents a share - Earnings Preview